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Can an online clinical data management service
help in improving data collection and data
quality in a developing country setting?
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Background: Data collection by Electronic Medical Record (EMR) systems have been proven to be helpful in data
collection for scientific research and in improving healthcare. For a multi-centre trial in Indonesia and the
Netherlands a web based system was selected to enable all participating centres to easily access data. This study
assesses whether the introduction of a Clinical Trial Data Management service (CTDMS) composed of electronic
Case Report Forms (eCRF) can result in effective data collection and treatment monitoring.
Methods: Data items entered were checked for inconsistencies automatically when submitted online. The data
were divided into primary and secondary data items. We analysed both the total number of errors and the change
in error rate, for both Primary and Secondary items, over the first five month of the trial.
Results: In the first five months 51 patients were entered. The Primary data error rate was 1.6%, whilst that for
Secondary data was 2.7% against acceptable error rates for analysis of 1% and 2.5% respectively.
Conclusion: The presented analysis shows that after five months since the introduction of the CTDMS the Primary
and Secondary data error rates reflect acceptable levels of data quality. Furthermore, these error rates were
decreasing over time. The digital nature of the CTDMS, as well as the online availability of that data, gives fast and
easy insight in adherence to treatment protocols. As such, the CTDMS can serve as a tool to train and educate
medical doctors and can improve treatment protocols.
Background
Data collection concerning medical needs is required to
assess the effectiveness of interventions and current
health care practices [1]. Furthermore, data collection by
Electronic Medical Record (EMR) systems has been pro-
ven to be helpful in data collection for scientific
research and can be helpful in improving healthcare.
These EMR systems allow for the early identification of
missing data and the patients possibly loss-to-follow-up,
which is essential for the conduct of proper scientific
research [2-6].
A Clinical Trial Data Management service (CTDMS)
has been introduced for running a multicenter clinical
trial in Indonesia and in the Netherlands. The same sys-
tem has also been introduced for monitoring treatment
results of Nasopharyngeal Carcinoma (NPC) in
Indonesia.
In most countries NPC is an orphan disease, but over-
all has a worldwide incidence of 80.0000 new cases per
year, being endemic in Northern Africa, Southern China
and Hong Kong, and the South-East Asian peninsula,
including Malaysia, Vietnam, Thailand, Singapore and
Indonesia.
In Indonesia NPC is the most frequent cancer in the
head and neck area and ranks as the 4th most common
tumour found in males. The incidence is estimated 6
per 100.000, leading to 12.000 new cases per year [7,8].
Little is known about treatment results of NPC in
Indonesia.
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The CTDMS system was selected because of the web-
based nature which makes the data approachable for all
participating parties. This online accessible data system
has made it easier for the principal investigator to check
the data for inconsistencies. The senior physician can
easily see if treatment is according protocol.
This study assesses whether the introduction of
CTDMS composed of online Case Report Forms (eCRF)
can result in improved patient outcomes. The assess-
ment focuses on data quality and the identification of
possible bottle necks within the patient care process.
This study investigates if a web based CTDMS can be
helpful in proper data collection by analysing errors in
data items. Bottle necks in patient care are analysed by
comparison of treatment plan and actual treatment.
Methods
The CTDMS is constructed for the NPC Clinical Trial:
Early detection of primary and recurrent NPC using
(anti-)EBV based tumour markers and evaluation of pri-
mary treatment for NPC (funding KWF NKI-2008-
4233). A technical description of the CTDMS is pro-
vided in Appendix 1. The database is comprised of 10
online eCRF’s. In order to prevent errors from being
entered, data validation rules were implemented into the
eCRF’s prior to commencement of the NPC Clinical
trial. These data validation rules assess whether certain
pre-specified conditions are valid and can therefore pin-
point omissions or erroneous data. Online warning mes-
sages notify the data-manager (entering data) when
errors are detected. Commonly used checks are, for
instance, range checks that verify whether values are
within the boundaries dictated by the study protocol,
and mandatory field checks (i.e. ‘This field cannot be
blank’).
Of the 10 eCRF’s, 9 were required to be completed
multiple times per patient during the study and only 1
was to be completed and submitted once per patient.
Each of these submissions is a unique realization of the
form. For example, for one patient a laboratory form is
completed during baseline measurements, just before
the start of the treatment. Once this form is submitted
through the CTDMS, there is one realization of the
laboratory form stored in the database for this patient.
After the patient received treatment, a laboratory form
is completed and submitted again. The data base then
contains two realizations of the laboratory form, for that
patient. Each realization may be submitted multiple
times if it contained errors. We note that it is impossi-
ble to claim that an entered form for which no warning
messages were displayed is clean, as new errors may be
found later.
The data-manager completing an eCRF has the option
to ignore (override) a warning message, however in such
cases, he/she is required to provide an explanation
which is recorded in an Audit Trail entry field (error
log). Warning messages and error logs are also created
when an incorrect value or data-type is entered, an
omission is detected, or when a previously entered value
is changed. Changed values are considered to be (pre-
viously undetected) errors that have now been rectified
(except when the changed value also triggers a check to
fire, in which case the data is considered unclean).
The eCRF’s contain differing quantities of data. Each
field to be entered is considered a data item, which were
designated either as primary or secondary. Primary data
items are data that were considered essential for the
assessment of the NPC Clinical trial primary endpoint,
and so for assessment of treatment protocol. Secondary
data items are data required to assess the clinical trial’s
secondary endpoints.
As acceptable levels of data quality, an 1% error rate
for primary and an 2.5% error rate for secondary data
points were adopted [9]. We present the change in error
rate over the course of the trial, the number of errors
per submission, and the change in data quality per form
per submission.
Results
Between November 2009 and March 2010 a total of
4860 data items pertaining to 51 patients were entered.
This is the first five months of an estimated 3 year long
accrual period. In total 433 eCRF’s were submitted, of
which 329 were unique realizations. Each CRF has been
submitted between 1 to 4 times. Table 1 presents an
overview of the submitted eCRF’s and data items.
Of the 433 submitted eCRF realizations, 287 were sub-
mitted for the first time without primary data errors
(Table 2), while 253 forms (realizations) were submitted
for the first time without secondary data errors (Table
3). No form had more than two errors in the primary
data. One form contained 10 secondary data errors
when it was submitted for the first time. This was base-
line patient registration data for which the wrong
patient was entered. In general subsequent submissions
contained fewer errors (Figure 1).
For example, the “Pathology, Staging & Given treat-
ment” eCRF contained a total of 89 unique data items,
with the number of data items per eCRF ranging from 2
to 18 (Table 1). Of these 89 items, 40 were classified as
primary data, with the remaining 49 being classified as
secondary. The error rate at first submission was 3.3%
for primary data and was 8.4% for secondary data.
To assess the change in data quality over time, the
proportion of unsolved errors in primary and secondary
data were plotted against time (in months). Figure 2(A)
presents the cumulative number of unique data items
submitted and the number of unresolved errors over the
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first five months of the study. Figure 2(B) presents the
change in the percentage of unresolved errors of pri-
mary and secondary data items. Although the absolute
number of unsolved errors is increasing with time (due
to the accrual of patients), the fraction of erroneous
data is declining. Five months after the start of study
the error rate for the primary data items was 1.6% and
for the secondary data items the error rate was 2.7%.
Although not quite at the levels appropriate for final
analysis, the standard of data quality is high, very early
into the study.
Discussion
For this study we found an error rate of 1.6% for pri-
mary data items, while in earlier studies in the same set-
ting data could not be analysed because of the massive
data loss and poor data quality. With this real time data
monitoring and inbuilt checks we have realized accepta-
ble levels of data quality. The CTDMS prevents us from
missing data or ending up with poor quality data at the
end of the study, which often at that point cannot be
resolved anymore.
The presented analysis shows that after five months
since the introduction of the CTDMS the error rates for
both Primary and Secondary data items reflect accepta-
ble levels of data quality. Furthermore these error rates
were decreasing over time. The drop in errors per form
with each form submission indicates that, while being
prompted by the CTDMS, the data manager and
responsible doctors are actively solving the errors.
Online warning messages notify the data manager
(entering data) when errors are detected, allowing them
to immediately correct the data, rather than the usual
delay associated with paper based CRFs.
Clearly, the CTDMS encourages local data managers
to verify the entered data and, if necessary, ask the doc-
tor whether the information is correct. It is also likely
that the reason that data managers have to specify argu-
ments before submitting the form in case the CTDMS
detects erroneous data motivates them to verify whether
the available data is actually correct. This may explain
why our results show a significant increase of clean data
and a self-learning curve of the data manager is to be
expected. Moreover, the error logs provide valuable
information about the bottlenecks in the treatment of
the NPC patients.
In the past authors have pointed out that existing data
collections in developing countries are often deficient
[10,11]. Eiseman and Fossum (2005) emphasize that
existing data collections are insufficiently comprehen-
sive, sometimes inaccurate, and often out of date by the
time the data can be acted upon. All point out that
without these data the required empirical knowledge to
address the health problems in developing countries is
Table 1 Number of times each form has been entered and the number of data items per form
Patients Forms* Data Items Primary Secondary Total Items
Patient information/Physic 51 75 18 7 11 1350
Radiology diagnostics 49 92 13 0 13 1196
New Complaint 3 4 2 0 2 8
PDT Reaction/Adverse event 1 2 3 0 3 6
General patient information 23 34 8 4 4 272
PDT Therapy form 2 2 6 6 0 12
Endoscopy/NPC Diagnostics 40 68 6 6 0 408
Primary Tumor & NPC Diagn. 2 2 14 5 9 28
Laboratory form 48 64 5 3 2 320
Pathology, Staging &
Given Treatment
48 90 14 9 5 1260
Totals: 433 89 40 49 4860
*Number of forms submitted, some unique realizations have been submitted multiple times.
Table 2 The number of forms submitted with erroneous
primary data items at each submission
Number of errors
0 1 2
Submission Number 1 287 31 11
2 78 9 2
3 8 3 0
4 3 1 0
For example 287 forms were entered error free at the first submission, while
four were entered for the fourth time, 3 error free and one with one error.
Table 3 The number of forms submitted with erroneous
secondary data items at each submission
Number of errors
0 1 2 3 4 10
Submission Number 1 253 19 39 15 2 1
2 76 2 8 3 0 0
3 9 0 2 0 0 0
4 4 0 0 0 0 0
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insufficient. Especially on strategic planning, priority set-
ting, monitoring and evaluation, advocacy, and general
policymaking [12-14].
These comments supported us on introducing an
online medical record system which could play an
important role in improving data collection and data
quality. Accordingly, during analysis we have also seen
that treatment procedures are often unsatisfactory. The
first analysis regarding the treatment of NPC has been
presented and discussed with all members of the disci-
plinary team. The main concern was the duration of the
radiotherapy. According to the protocol the duration for
administering the 66 gray radiotherapy should take to
the utmost 42 days, yet analysis showed that the treat-
ment time takes in average 66 days, which will lead to
inadequate treatment [15,16]. Future analysis has to
show if intervention by CTDMS system-based education
of the doctors will eventually lead to better treatment
outcome. The digital nature of the CTDMS, as well as
the online availability of data, gives fast and easy insight
in adherence to treatment protocols. As such, the
CTDMS can serve as a tool to directly train and educate
medical doctors. Therefore, a potential even bigger
advantage of an online medical record system is the
ability to monitor the data from the teaching hospitals

Figure 1 Errors per submission for the six forms of the nine forms for which there have been more than one submission (per
realization).
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Figure 2 (A) The cumulative number of unique data items
entered (black), the number of primary data items entered
(blue solid) and errors unresolved (blue dashed), the number
of secondary data items entered (red solid) and errors
outstanding (dashed lines). (B) The percentage of Primary (blue)
and Secondary (red) errors unresolved over time. The horizontal
lines are the targets for a final analysis.
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especially in developing countries. Via this way the tea-
chers can communicate directly or visit the participating
hospitals with a custom fit teaching program, which will
make such visits more effective.
Conclusion
We show that an online clinical data management ser-
vice can improve data quality in a developing country
setting. In the future we expect to see both less loss-to-
follow-up and better treatment programmes with help
of this CTDMS. For better and more efficient medical
care programs and studies in developing countries we
believe an online data system is essential.
The digital nature of the CTDMS, as well as the
online availability of that data, gives fast and easy insight
in adherence to treatment protocols. As such, the
CTDMS can serve as a tool to train and educate medi-
cal doctors and can improve treatment protocols. Since
the introduction of this system training the doctors has
become much more efficient.
Appendix 1
Technical description CTDMS
The selected CTDMS is ALEA™ 3.0, which uses Micro-
soft Infopath 2007 for eCRF template design and Share-
point Enterprise 2007 for rendering the eCRF’s in
Table 4 List of filters/rules which trigger error flags
Name eCRF Data item Data validation rule
Patient
information/
Physical
examination form
Date of First Visit 1. The field Date of First Visit is mandatory and cannot be blank.
2. The Date of First Visit cannot be after the Date of today
Date of Birth 1. The patient Date of Birth cannot be blank
2. The patient Date of Birth cannot be after the current date.
3. The Date of birth you entered is before 1-1-1900, the patient is too old to participate in this study
Date of Signed
informed consent
1. The field “Date of Signed informed consent” is mandatory and cannot be left blank
2. The Date of First Visit cannot be after the Date of today
1. The field Heart Rate cannot be blank.
2. The field “heart rate” cannot be more than 220 p/m
3. The field “heart rate” cannot be less than 40 p/m
Temperature 1. Patient Temperature should be between 35 and 41.5 degrees
WHO performance
rate”
1. The field “performance rate” is mandatory and cannot be left blank
2. During First Visit, the “WHO performance rate” cannot be either 3 or 4.
Radiology
Diagnostics form
CT/MRI- scan Date
Sample Taken
1. The field CT/MRI- scan Date Sample Taken is mandatory and cannot be blank.
2. The Date of sample taken, CT/MRI-scan, cannot be before the Date of Visit, as specified on the
General Patient Information form (belonging to this Event/Visit).
3. The Date Sample Taken CT/MRI- scan cannot be before the Date of First Visit.
4. The Date Sample Taken CT/MRI- scan during PDT Assessment should be about 12 weeks after the
Date of Foscan Administration and no less than 10 weeks after that date.
5. The Date of CT/MRI- scan cannot be later than today.
T-stage 1. The T-stage (0,1,2A and 2B,3,4) in the field “CT-MRI T-stage” has to be the same as the T (0,1,2A and
2B,3,4) in the field “T-stage” on the Pathology form.
2. The T- stage cannot be “0” if patient has been included in this study because of a recurrent or
persistent disease
field CT/MRI Lesion
Size
1. The field CT/MRI Lesion Size (length) cannot be blank when the field T-stage has been entered.
2. The field CT/MRI Lesion Size (length) cannot be more than 200 mm
CT/MRI site 1. The field “CT/MRI site” is mandatory and cannot be left blank
2. The tumour site CT/MRI- scan selected here differs from the Suspicious site as specified on the
Endoscopy form during this Visit. Are you sure this is correct? If yes, please provide explanation in
Audit Trail entry after Validation
3. The tumour site CT/MRI- scan selected here differs from the Tumour site as specified on the
Endoscopy form during this Visit. Are you sure this is correct? If yes, please provide explanation in
Audit Trail entry after Validation
endoscopy 1. If Nose endoscopy has been performed, the field Date of Endoscopy cannot be blank
2. During (visit) Positive Test, the Date of Endoscopy should be after the Date of Endoscopy of the
PDT Assessment.
3. The Date of Endoscopy should be after the Date of Endoscopy of the last PDT Follow Up
4. The Date of Endoscopy should be after the Date of Endoscopy of the PDT Visit(s)
5. The Date of Endoscopy should be after the Date of Endoscopy of the previous Follow Up visit.
6. The Date of Endoscopy should be after the Date of Endoscopy of the First Visit.
7. The Date of Endoscopy should be 3 months after the Date of Endoscopy of the Therapy
Assessment
Examples of data validation rules triggering error flags for a subset of the data items on two of the eCRF’s.
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browsers. SQL server 2008 is used for data storage. The
CTDMS provides a comprehensive eCRF. It uses stan-
dard browsers running on any computer connected to
the internet. The system has been validated, and has
been certified by registered auditors, as being in compli-
ance with relevant regulations, such as the FDA’s CFR
21 Part 11.
The CTDMS eCRF design module is based on an
industry grade enterprise electronic forms system:
Microsoft Infopath 2007 for form design and Microsoft
Forms Server 2007 for data entry. The components
make use of a common standard representation of data
and metadata: the Operational Data Model of CDISC.
Within the CTDMS, the components share a database
for storing and retrieving information about the trial,
and a separate database for storing and retrieving
patient data.
The online Data Management Module of the CTDMS
is a web browser application that supports online com-
pletion of eCRF for healthcare studies. It requires initial
login with a username and password, and provides a
navigation menu for all trials to which the account has
been granted access, and the selected investigators for
which the account has been granted permissions to
access. Transmission of data is SSL encrypted using
RSA 1024 bit Public Key encryption.
Data validation rules were implemented into the
eCRF’s using the tools Microsoft Office InfoPath pro-
vides, as well as some Xpath expressions. With data vali-
dation rules implemented, the eCRF automatically
checks the data as soon as it is entered. If a value does
not match the specified condition, an error alert pro-
vides the user with immediate feedback. Moreover, after
completion of an eCRF, the user is prompted to provide
an explanation of all data items which raised validation
errors. This enables users to submit data with validation
errors, while providing a comprehensive audit trail in
compliance with requirements from regulatory authori-
ties. Examples of data validation rules, which trigger
error flags is provided in Table 4.
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